Scientific excellence that achieves new standards of care drives the company's work. Over 20 products are currently in clinical development addressing a variety of key medical needs.

In addition to Biogen Idec's promising portfolio of drug candidates, the company's capabilities and capacity for protein manufacturing are world-class in quality and scale. The company is one of a handful of biotechnology companies that has three licensed and dedicated biological bulk-manufacturing facilities, in ...